Skip to content

Can I take ginkgo with warfarin?

Short answer: Use caution: the warfarin label says ginkgo may cause bleeding; Europe's herbal regulator says it may increase anticoagulant effects and advises monitoring, though warfarin studies did not indicate an interaction; veterans' records found more bleeding.

Use caution. Ginkgo is on the warfarin label, which names it among botanicals that "may cause bleeding events when taken alone" and says these effects "would be expected to be additive to the anticoagulant effects of JANTOVEN." Europe's herbal medicines committee says ginkgo "may increase the effects of anticoagulants" and that "Available studies with warfarin do not indicate that there is an interaction", and it advises monitoring. In US veterans' records, ginkgo users on warfarin had more bleeding events.

How well documented: On the drug’s label. The medicine’s FDA-approved label names this supplement, or the kind of product it is.

What's known

  • On the label. The warfarin (Jantoven) label says: "Some botanicals may cause bleeding events when taken alone (e.g., garlic and Ginkgo biloba) and may have anticoagulant, antiplatelet, and/or fibrinolytic properties. These effects would be expected to be additive to the anticoagulant effects of JANTOVEN." It also says: "Some botanicals and foods can interact with JANTOVEN through CYP450 interactions (e.g., echinacea, grapefruit juice, ginkgo, goldenseal, St. John's wort)." And: "More frequent INR monitoring should be performed when starting or stopping botanicals." It also says: "Few adequate, well-controlled studies evaluating the potential for metabolic and/or pharmacologic interactions between botanicals and JANTOVEN exist. Due to a lack of manufacturing standardization with botanical medicinal preparations, the amount of active ingredients may vary. This could further confound the ability to assess potential interactions and effects on anticoagulation." Its counselling section says to advise patients to: "Not take or discontinue any other drug, including salicylates (e.g., aspirin and topical analgesics), other over-the-counter drugs, and botanical (herbal) products except on advice of your physician [see Drug Interactions (7)]." (Warfarin label)
  • Studies with warfarin. The European Medicines Agency's herbal medicines committee, in its monograph on ginkgo leaf, says: "If the medicinal product is taken concomitantly with anticoagulants (e.g. phenprocoumon and warfarin) or antiplatelet drugs (e.g. clopidogrel, acetylsalicylic acid and other non-steroidal anti-inflammatory drugs), their effect may be influenced." It adds: "Available studies with warfarin do not indicate that there is an interaction between warfarin and G. biloba products, but adequate monitoring is advised when starting, when changing G. biloba dose, when ending G. biloba intake or if changing product." Beside it, for traditional-use products, it says: "Ginkgo leaf may increase the effects of anticoagulants such as coumarin derivatives." In a crossover study of 12 healthy men, each given a single warfarin dose, "The mean ratio (90% CI) of AUC(0-168) of INR was 0.93 (0.81-1.05) when coadministered with ginkgo." A ratio of 1 would mean no change; the study was small and short. (EMA ginkgo monograph; Jiang 2005)
  • Veterans' health records. An observational study of US veterans' records, published as a conference paper, reports: "Our statistical analysis suggests that taking concurrently with warfarin, gingko does significantly increase patients' risk of a bleeding adverse event (hazard ratio = 1.38, 95%CI: 1.20 to 1.58, p<.001)." (The quote keeps the abstract's spelling.) A study of records can show a link but cannot prove that ginkgo caused the bleeding. (Stoddard 2015)

What to do

  • Ginkgo and bleeding: in an observational study of US veterans' health records, published as a conference paper, people taking warfarin who also took ginkgo had more bleeding events (hazard ratio 1.38; PubMed 26958257). Clotting tests did not change in 18 randomised trials (PubMed 21923430), but those were laboratory tests, not bleeding events. A systematic review found 15 published case reports of bleeding in people using ginkgo, including 8 episodes of intracranial bleeding (bleeding inside the skull), and concluded that they suggest 'a possible causal association between using ginkgo and bleeding events' (PubMed 16050865).
  • The European Medicines Agency's herbal medicines committee (HMPC), in its monograph on ginkgo leaf, says: 'The use in children and adolescents under 18 years of age is not recommended.' It lists as a contraindication: 'Hypersensitivity to the active substance.' It says: 'In patients with a pathologically increased bleeding tendency (haemorrhagic diathesis) and concomitant anticoagulant and antiplatelet treatment, the medicinal product should only be used after consultation with a doctor.' 'Preparations containing Ginkgo might increase susceptibility to bleeding, the medicinal product should be discontinued as a precaution 3 to 4 days prior to surgery.' 'In patients with epilepsy, onset of further seizures, promoted by intake of Ginkgo preparations, cannot be excluded.' 'Concomitant use of Ginkgo biloba containing products and efavirenz is not recommended.' 'An interaction study with talinolol indicates that G. biloba may inhibit P-glycoprotein at the intestinal level. This may give rise to increased exposure of drugs markedly affected by P-glycoprotein in the intestine such as dabigatran etexilate. Caution is advised if combining G. biloba and dabigatran.' It says 'The use is contraindicated in pregnancy' and 'In the absence of sufficient data, the use during lactation is not recommended.' It lists as undesirable effects: 'Bleeding of individual organs has been reported (eye, nose, cerebral and gastrointestinal haemorrhage).' 'Very common: headache', 'Common: dizziness', 'Common: diarrhoea, abdominal pain, nausea, vomiting' 'Gastrointestinal disorders, headaches and allergic reactions have been reported.' 'Hypersensitivity reactions (allergic shock) may occur.' 'Allergic skin reactions (erythema, oedema, itching and rash) may also occur.'
  • The warfarin Medication Guide says: "Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements. Some of your other medicines may affect the way JANTOVEN works. Certain medicines may increase your risk of bleeding." It also says: "For more information, ask your healthcare provider or pharmacist." (Warfarin label)
  • Don't stop or change a prescribed medicine on your own.

Sources

  1. US National Library of Medicine. Jantoven (warfarin sodium) tablets: prescribing information and Medication Guide. DailyMed, revised October 2026. DailyMed
  2. European Medicines Agency, Committee on Herbal Medicinal Products. European Union herbal monograph on Ginkgo biloba L., folium (EMA/HMPC/321097/2012). Adopted 28 January 2015. EMA
  3. Jiang X, et al. Effect of ginkgo and ginger on the pharmacokinetics and pharmacodynamics of warfarin in healthy subjects. Br J Clin Pharmacol. 2005. PubMed 15801937 · doi:10.1111/j.1365-2125.2005.02322.x
  4. Stoddard GJ, et al. Ginkgo and Warfarin Interaction in a Large Veterans Administration Population. AMIA Annu Symp Proc. 2015. PubMed 26958257
  5. Kellermann AJ, et al. Is there a risk of bleeding associated with standardized Ginkgo biloba extract therapy? A systematic review and meta-analysis. Pharmacotherapy. 2011. PubMed 21923430 · doi:10.1592/phco.31.5.490
  6. Bent S, et al. Spontaneous bleeding associated with ginkgo biloba: a case report and systematic review of the literature. J Gen Intern Med. 2005. PubMed 16050865 · doi:10.1111/j.1525-1497.2005.0121.x